OBJECTIVES: To determine human PPARg coactivator-1 (PGC-1) amino acid sequence and to study PGC-1 mRNA tissue distribution. PGC-1 is a novel transcriptional coactivator of nuclear receptors that may play a role in the control of thermogenesis. SUBJECTS: Subcutaneous adipose tissue was obtained from six obese and ®ve lean male subjects. Vastus lateralis skeletal muscle was obtained from seven lean and six obese subjects undergoing a 5-day severe calorie restriction. Other tissue biopsies were from nonobese nondiabetic subjects. METHODS: Human PGC-1 was cloned from a skeletal muscle cDNA library. A reverse transcription-competitive polymerase chain reaction assay was developed to determine PGC-1 mRNA levels in human tissues. RESULTS: The human amino acid sequence showed 95% identity with mouse PGC-1. PGC-1 mRNA was expressed at very low levels in the small and large intestines and white adipose tissue. Heart, kidney, liver and skeletal muscle showed higher mRNA levels. The degree of obesity did not affect PGC-1 mRNA levels in adipose tissue while lean subjects expressed more PGC-1 mRNA than obese subjects in skeletal muscle. A 5-day severe calorie restriction induced PGC-1 mRNA expression in skeletal muscle of obese but not of lean subjects. CONCLUSION: PGC-1 shows a restricted tissue expression that suggests a tissue-speci®c role in the control of gene transcription and possible interaction with various members of the PPAR family. The lower expression of skeletal muscle PGC-1 in obesity could contribute to an alteration of mitochondrial gene expression.
Introduction
Obesity is characterized by a chronic imbalance between energy intake and expenditure. A reduced rate of energy expenditure is a risk factor for body weight gain.
1 Part of energy expenditure results from a leaking of protons across the mitochondrial inner membrane which leads to energy dissipation because of uncoupling of oxygen consumption to ATP synthesis. To date, three mitochondrial uncoupling proteins, designated UCP1, UCP2 and UCP3, are candidates to explain the proton leak. 2 The most compelling evidence of a direct role of uncoupling proteins in the proton leak comes from data on brown fat-speci®c UCP1. During cold exposure, energy dissipation is increased through brown adipose tissue (BAT) hypertrophy, biogenesis of mitochondria, and increased expression and activation of UCP1. 3 In adult humans, the contribution of BAT in energy expenditure is more elusive. UCP2 and UCP3, two other members of the mitochondrial carrier family with uncoupling properties, have recently been identi®ed 4 ± 7 and are proposed to be involved in the control of energy expenditure in humans. 8, 9 Recent data have pointed to peroxisome proliferator-activated receptor g (PPARg) as a transcriptional regulator of uncoupling protein expression. PPARg is a nuclear receptor activated by fatty acids and eicosanoids which plays a major role in adipocyte differentiation. 10 In brown fat cells, PPARg activates an enhancer of the UCP1 gene promoter. 11 PPARg could also be involved in the fatty acid-dependent activation of UCP2 and UCP3 expression. 12 ± 17 Other factors, such as thyroid hormones and catecholamines, which are important regulators of energy expenditure, are known to modulate uncoupling protein gene expression. 2,18 ± 21 Recently, Spiegelman and co-workers identi®ed a novel coactivator of nuclear receptors, termed PPARg coactivator-1 (PGC-1), which increases the transcriptional activities of PPARg and thyroid hormone receptor on the UCP1 promoter and promotes expression of several mitochondrial proteins in BAT. 22 Mouse PGC-1 mRNA is expressed in BAT, heart, kidney and brain. Upon cold exposure, PGC-1 mRNA is induced in BAT and skeletal muscle. Treatment of H1B1B brown fat cells with a b-adrenergic agonist results in an increase in both PGC-1 and UCP1 mRNA. To date, no data on human PGC-1 have been reported. In the present work, we studied human PGC-1 mRNA expression. Human PGC-1 cDNA was cloned to obtain the complete amino acid sequence. The cDNA was used to construct a competitor DNA for reverse transcription ± competitive polymerase chain reaction (RT-competitive PCR) analysis. The pattern of human PGC-1 mRNA expression was compared to the tissue distribution of the transcripts encoding the various forms of PPARs. We previously showed that a 5-day severe calorie restriction results in an induction of UCP2 and UCP3 mRNA in skeletal muscle. 23, 24 To investigate a potential parallel induction of PGC-1 and uncoupling proteins, we determined PGC-1 mRNA levels during severe calorie restriction in lean and obese subjects.
Subjects and methods

Subjects
Liver, heart, small and large intestines, visceral adipose tissue and kidney biopsies were obtained from nonobese nondiabetic subjects undergoing elective surgery. Subcutaneous adipose tissue was obtained from six obese (mean AE s.d.; age 57 AE 7 y, BMI 30AE 2 kgam 2 ) and ®ve lean (age 20 AE 1 y, BMI 21AE 3 kgam 2 ) male subjects. Vastus lateralis skeletal muscle was obtained from seven lean (one man and six women, age 50 AE 5 y, BMI 22 AE 2 kgam 2 ) and six obese (two men and four women, age 41 AE 12 y, BMI 36AE 4 kgam 2 ) subjects undergoing a 5-day severe calorie restriction (1045 kJaday) as previously described. 23 The ®rst biopsies were performed after an overnight fast before the beginning of the calorie restriction. The second biopsies were performed the morning of the sixth day of calorie restriction. Samples were immediately frozen in liquid nitrogen and stored at 7 80 C. None of the obese subjects was on regular medication and showed known complications of obesity, such as established hypertension, diabetes or dyslipidaemia. All subjects were Caucasians. Subjects had given written consent and the experimental protocols were approved by the ethics committee of Hospices Civils de Lyon.
Cloning of human PGC-1
Comparison of the mouse PGC-1 cDNA sequence with a nonredundant database (dbest) containing expressed sequence tags (EST) revealed four human sequences with high sequence identity to mouse PGC-1 cDNA. Two overlapping sequences (accession numbers AA865326 and AA188859) covered nt 442 ± 803 from the translational start site. A third EST (accession number AA413411) extended from nt 1189 to 1342. The fourth EST (accession number AA188803) corresponded to a region of the 3 H noncoding sequence. RT-PCR was performed on human skeletal muscle total RNA using a sense primer (5 H -TCC TCT GAC CCC AGA GTC AC-3 H , nt 777 ± 796) and an antisense primer (5 H -TAG AGT CTT GGA GCT CCT G-3 H , nt 1202 ± 1220) derived from the EST sequences. The 443 bp amplicon was cloned into the pGEM-T Easy vector (Promega) and sequenced by automatic DNA sequencing (ABI Prism 310 Genetic Analyzer, Perkin Elmer Applied Biosystems). A competitor DNA was obtained by a deletion of 30 bp using a two-step PCR overlap extension method. The complete coding sequence of human PGC-1 cDNA was ampli®ed from a human skeletal muscle pGAD10 library (Clontech) using various combinations of primers derived from known human PGC-1 cDNA sequences and from the pGAD10 vector. A combination of DNA polymerases (AmpliTaq, Perkin Elmer and Vent, New England Biolabs in a ratio of 1:12 in DNA polymerase units) that ensures high-®delity ampli®cation and automatic sequencing of at least three independent clones was used to obtain the correct sequence.
Quanti®cations of PGC-1 and PPAR mRNA levels PGC-1 mRNA level was quanti®ed by RT-competitive PCR 25 using the primers and the competitor DNA described above. The reverse transcription reaction was performed in the presence of a thermostable reverse transcriptase (Tth, Promega), using the speci®c antisense primer. 25 The RT-competitive PCR assay was validated using various quantities (from 0.01 to 1 amol) of in vitro synthesized PGC-1 RNA. The different PPAR mRNA levels were determined by RT-competitive PCR as previously described. 26 
Data analysis
Values are given as meansAE s.e.m. The nonparametric Wilcoxon test for paired values was used for comparisons before and during fasting. The nonparametric U Mann ± Whitney test for unpaired values was used for comparisons between groups of subjects. Statistical calculations were performed using Statview (Abacus Concepts). P`0.05 was the threshold of signi®cance.
Results
The complete coding sequence of human PGC-1 was cloned and sequenced (accession number AF159714). The deduced amino acid sequence showed 95% identity with mouse PGC-1 (Figure 1) . The 798 amino acid-long human PGC-1 differed from the mouse sequence by two insertions and one deletion in the N-terminal part of the protein. The peptide motifs Human PGC-1 mRNA expression D Larrouy et al described by Puigserver et al were entirely conserved between the two species. 22 The domain of interaction with PPARg showed 87% identity between mouse and human PGC-1. Figure 2 shows PGC-1 mRNA levels in human tissues. Kidney and heart expressed comparable amounts of PGC-1 mRNA. Slightly lower levels were found in liver and skeletal muscle. Subcutaneous adipose tissue expressed low levels of PGC-1 mRNA. The levels found in the intestines and visceral adipose tissue were close to the limit of detection of the assay. The degree of obesity did not affect PGC-1 mRNA levels in subcutaneous adipose tissue, while lean subjects expressed more PGC-1 mRNA than obese subjects in skeletal muscle (P 0.01). The comparison of PGC-1 and PPAR mRNA levels (Figure 3) showed that the two tissues expressing the highest quantities of PPARg mRNA, i.e. white adipose tissue and the large intestine, expressed very low levels of PGC-1 mRNA. In liver and skeletal muscle, the relatively high expression of PGC-1 mRNA was associated with a high expression of PPARa.
We previously showed that a 5-day severe calorie restriction results in a 2 ± 3-fold increase in skeletal muscle UCP2 and UCP3 mRNA levels. The induction was similar in lean and obese subjects and the mRNA levels did not differ in the two populations before the diet. 23, 24 The effect of fasting on skeletal muscle PGC-1 mRNA levels was studied in the same groups of patients (Figure 4) . In lean subjects, there In obese subjects, the hypocaloric diet induced a 2-fold increase in mRNA levels (P`0.05) that reached after the diet the levels found in lean subjects. No correlation was found between PGC-1 and UCP2 and UCP3 mRNA levels before and during the diet (r 0.3 ± 0.5, P b 0.1). During calorie restriction, changes in PGC-1 mRNA level were not associated with changes in UCP2 and UCP3 mRNA levels (r 0.1 ± 0.4, P b 0.2).
Discussion
The recent characterization of a novel coactivator of nuclear receptors, PGC-1, linked to adaptive thermogenesis has shed new light on transcriptional mechanisms involved in the expression of mitochondrial proteins. The purpose of the present work was to study the tissue distribution of PGC-1 mRNA in humans and to investigate a possible relationship between PGC-1 and PPAR and uncoupling protein mRNA expression.
The human amino acid sequence showed very high sequence identity with mouse PGC-1. The three consensus sites for phosphorylation by protein kinase A are identical in the two species. PGC-1-mediated transcriptional activation is stimulated by cAMP raising the possibility that phosphorylation of PGC-1 by protein kinase A modulates its activity. 22 A characteristic feature of the coactivator is the presence of paired SR-rich and RNA binding domains which are identical in the two species. The leucine-rich motif LXXLL in the N-terminal part of the protein may mediate binding of PGC-1 to liganded nuclear receptors. 27, 28 The region of interaction with PPARg (aa 292 ± 338 in the mouse sequence) is however different. This organization suggests that PGC-1 may interact with several classes of nuclear receptors with or without ligand dependence. 22 The pattern of PGC-1 mRNA expression was studied using a quantitative RT-competitive PCR assay. Kidney and heart expressed the highest PGC-1 mRNA level, which is in accordance with the data obtained in the mouse. 22 An unexpected observation was the relatively high expression of PGC-1 in human liver. PGC-1 mRNA was not detected in mouse liver using Northern blot analysis. 22 The vastus lateralis muscle expressed levels of PGC-1 mRNA comparable to the liver. Human liver and skeletal muscle expressed low mRNA levels of PPARg, the subtype of PPAR initially shown to interact with PGC-1. 22 However, the main form of PPAR in the two tissues was PPARa. Interestingly, the region of human PPARg binding to PGC-1 showed 75% amino acid sequence identity with the corresponding region in human PPARa. In view of the coexpression of PPARa and PGC-1, the study of a functional interaction between the two proteins is of interest. The levels of PGC-1 mRNA were very low in the large intestine and white adipose tissues, suggesting that, in humans as in rodents, PGC-1 may be involved in tissue-speci®c regulation of gene expression. It is important to note that the two tissues expressed the highest levels of PPARg mRNA. In adult humans, a few brown fat cells are interspersed into white fat deposits. Higher expression of UCP1 mRNA has been reported in visceral than in subcutaneous fat depots. 29 Figure 3 Comparison of PGC-1 and PPAR mRNA levels in human tissues. Determinations of mRNA levels were performed on each sample using RT-competitive PCR. The number of independent tissue samples is indicated in parentheses. Subcutaneous white adipose tissue (adipose tissue) and skeletal muscle (skel. muscle) were obtained from lean individuals. Int., intestine.
Human PGC-1 mRNA expression D Larrouy et al Therefore, we determined PGC-1 mRNA levels in the two depots. Visceral adipose tissue did not show higher expression than subcutaneous adipose tissue. Studies of perirenal fat depots of patients with adrenal pheochromocytoma, a pathological condition characterized by the development of BAT and UCP1 expression, 30 could help to determine the level of PGC-1 mRNA in human brown adipocytes. PGC-1 interacts with thyroid hormone receptor and increases its transcriptional activity on the UCP1 promoter. 22 The tissues expressing PGC-1 also express thyroid hormone receptors, 31, 32 suggesting a possible role for the coactivator in thyroid hormone-mediated effects on mitochondrial gene expression.
The relationship between obesity and PGC-1 mRNA expression was studied in subcutaneous white adipose tissue and skeletal muscle. No difference was observed in white adipose tissue. Obese subjects expressed less PGC-1 mRNA than lean subjects in skeletal muscle. Mitochondrial skeletal muscle metabolic activity is altered in obesity. 33 If PGC-1 is involved in the control of mitochondrial gene expression in humans, the lower expression in skeletal muscle could therefore contribute to the obesity-related alteration. In humans, skeletal muscle is an important determinant of energy expenditure and a role for UCP2 and UCP3 has been suggested. The link between PGC-1 and the transcription program during adaptive thermogenesis in rodents prompted us to examine the relationship between uncoupling protein and PGC-1 mRNA expression. A 5-day severe calorie restriction results in a 2 ± 3-fold induction that is similar in lean and obese subjects. 23, 24 PGC-1 mRNA levels was increased during fasting in obese subjects but not in lean subjects. No correlation was found between PGC-1 and UCP2 and UCP3 mRNA levels. Therefore, variations in PGC-1 mRNA levels do not seem to be associated with the upregulation of UCP2 and UCP3 mRNA during fasting. Changes in metabolic parameters during fasting and other in vivo studies in rats and humans 13, 15 suggest that fatty acids may stimulate UCP2 and UCP3 gene expression. PPARs are activated by fatty acids and other lipid metabolites and may participate in the control of uncoupling protein gene expression. 12, 14, 16, 17 It is possible that fatty acids directly stimulate PPAR activity on UCP2 and UCP3 gene promoters without change in PGC-1 expression level. However, the data do not exclude the possibility that PGC-1 may participate in the transcriptional regulation of UCP2 and UCP3.
To conclude, we report in this paper the amino acid sequence and mRNA tissue distribution of human PGC-1. mRNA expression was observed in heart, kidney, liver and skeletal muscle. In these tissues, the coactivator could interact with PPAR and other nuclear receptors. In skeletal muscle, PGC-1 mRNA levels were lower in obese than in lean subjects. During fasting, the induction of skeletal muscle UCP2 and UCP3 mRNA levels was not associated with parallel variations in PGC-1 mRNA levels. 
